Kilitch Drugs India Ltd reports jump in consolidated PAT to Rs. 2.89 crores in FY22

Kilitch Drugs (India) Limited has reported Consolidated financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 36.9858 crores during the period ended March 31, 2022 as compared to Rs. 35.7404 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 2.8982 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 1.1249 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 1.86 for the period ended March 31, 2022 as compared to Rs. 0.72 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 36.9858 crs	₹35.7404 crs	3.48%
Net Profit	₹2.8982 crs	₹1.1249 crs	157.64%
EPS	₹1.86	₹0.72	158.33%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 36.9858 crores during the period ended March 31, 2022 as compared to Rs.21.4393 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.2.8982 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.0.7085 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.1.86 for the period ended March 31, 2022 as compared to Rs.0.46 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 36.9858 crs	₹21.4393 crs	72.51%
Net Profit	₹2.8982 crs	₹0.7085 crs	309.06%
EPS	₹1.86	₹0.46	304.35%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.117.1435 crores during the Financial Year ended March 31, 2022 as compared to Rs.71.1904 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.7.3673 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.3.6711 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.4.73 for the Financial Year ended March 31, 2022 as compared to Rs.2.37 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹117.1435 crs	₹71.1904 crs	64.55%
Net Profit	₹7.3673 crs	₹3.6711 crs	100.68%
EPS	₹4.73	₹2.37	99.58%

Shares of Kilitch Drugs (India) Limited was last trading in BSE at Rs. 152.05 as compared to the previous close of Rs. 148.95. The total number of shares traded during the day was 108 in over 7 trades.

The stock hit an intraday high of Rs. 155.95 and intraday low of 148.95. The net turnover during the day was Rs. 16126.00.

Source : Equity Bulls

Keywords

KilitchDrugsIndia Q4FY22 FY2022 ResultUpdate